Vesicor Therapeutics and Black Hawk Acquisition Corporation Announce Closing of Business CombinationGlobeNewsWire • 1h
Black Hawk Acquisition Corporation Announces Redemption Results in Connection With Its Business Combination With Vesicor Therapeutics Inc.GlobeNewsWire • 10/14/26
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive OfficerGlobeNewsWire • 03/19/26
Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered Via MicrovesiclesGlobeNewsWire • 04/28/25
CORRECTION: Black Hawk Acquisition Corporation Welcomes Mr. Jonathan Ginsberg to BoardGlobeNewsWire • 04/24/24
Black Hawk Acquisition Corporation Announces Closing of $69,000,000 Initial Public OfferingGlobeNewsWire • 03/22/24
Black Hawk Acquisition Corporation Announces Pricing of $69,000,000 Upsized Initial Public OfferingGlobeNewsWire • 03/20/24